Descripción
La descripción detallada está siendo preparada por nuestro equipo clínico.
Ensayos Clínicos
NCT06120283
Fase 1
Reclutando
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
United States, Australia, Brazil, China, France, Japan, Malaysia, Moldova, New Z
NCT06257264
Fase 1
Activo, no reclutando
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
United States, Australia, China, Israel, Moldova, New Zealand